BCL2 and neoplasm: Importantly, Mer dysregulation has been pathologically linked to oncogenesis: overexpression in tumor cells enhances survival under chemotherapy (via BCL-2 upregulation), facilitates metastatic dissemination (through EMT activation), and fosters immunosuppressive microenvironments (by polarizing tumor-associated macrophages) [5,6,7,8].